Phosphoramidate alkylator prodrugs can be used to treat cancer when administered along or in combination with one or more anti-neoplastic agents.
磷酰胺酰化烷基化剂前药可以在单独或与一个或多个抗肿瘤剂联合使用时用于治疗癌症。
Phosphoramidate Alkylator Prodrugs
申请人:Matteucci Mark
公开号:US20110251159A1
公开(公告)日:2011-10-13
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
磷酰胺烷基化剂前药可单独或与一个或多个抗肿瘤药物联合使用,用于治疗癌症。
Phosphoramidate alkylator prodrugs
申请人:Threshold Pharmaceuticals, Inc.
公开号:EP2336141A2
公开(公告)日:2011-06-22
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more other anti-neoplastic agents.